Fig. 4
From: Oligoclonality of CD8+ T Cells in Breast Cancer Patients
Comparison of the oligoclonal frequency of CD8 + T cells in breast cancer and non-breast cancer patients
Frequency of oligoclonality is determined by comparing the number of samples containing a dominant band in each Vβ gene family with the total number of samples analyzed. (A) PBMC: blood sample; (B) LN: lymph node sample.